Public Resources

Since the Administration released its drug pricing proposal (the "blueprint") earlier this year, virtually all health care stakeholders have engaged in robust discussions about the specific policies contained in the plan. The National Alliance has provided its members with updates, submitted comment letters, and continued to follow national discussions on drug pricing issues. This viewpoint summarizes specific proposals and offers insights from a purchaser perspective.